Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBITDA ratio is N/A as of 2026-10-06T18:51:10.992Z.
Calculation as of: 2026-10-06T18:51:10.992Z.
Quote observation: 2026-10-06T18:25:21.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 47abfa0c1c9b7ee8852b85727c09e566e291b91d06fb52154cb7b2e7f04347a4
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBITDA RATIO
N/A
Drugs Made In America Acquisition II Corp. Ordinary Shares
Market Cap
$648.78M
EV/EBITDA Ratio
N/A
| NAME | MARKET CAP | EV/EBITDA RATIO |
|---|---|---|
| Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII) | $648.78M | N/A |
| Capital Bancorp, Inc. (CBNK)vs › | $646.15M | N/A |
| Tiptree Inc. (TIPT)vs › | $647.60M | N/A |
| ACNB Corporation (ACNB)vs › | $651.83M | N/A |
| New Mountain Finance Corporation (NMFC)vs › | $644.64M | N/A |
| West Coast Community Bancorp (WCCB)vs › | $644.49M | N/A |
| CoinShares PLC Ordinary Shares (CSHR)vs › | $654.95M | N/A |
| Chaince Digital Holdings Inc. (CD)vs › | $661.89M | N/A |
| Coastal Financial Corporation (CCB)vs › | $636.64M | N/A |
| BlackRock Multi-Sector Income Trust (BIT)vs › | $635.68M | N/A |
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
